HPQ » Topics » Equity price risk

This excerpt taken from the HPQ 10-K filed Dec 17, 2009.

Equity price risk

        We are also exposed to equity price risk inherent in our portfolio of publicly-traded equity securities, which had an estimated fair value of $5 million at October 31, 2009 and $5 million at October 31, 2008. We monitor our equity investments for impairment on a periodic basis. Generally, we do not attempt to reduce or eliminate our market exposure on these equity securities. However, we may use derivative transactions to hedge certain positions from time to time. We do not purchase our equity securities with the intent to use them for speculative purposes. A hypothetical 30% adverse change in the stock prices of our publicly-traded equity securities would result in a loss in the fair values of our marketable equity securities of $1 million at October 31, 2009 and $2 million at October 31, 2008. The aggregate cost of privately-held companies, marketable trading securities and other investments was $142 million at October 31, 2009 and $425 million at October 31, 2008.

75


Table of Contents


ITEM 8. Financial Statements and Supplementary Data.

Table of Contents

Reports of Independent Registered Public Accounting Firm

 
77

Management's Report on Internal Control Over Financial Reporting

 
79

Consolidated Statements of Earnings

 
80

Consolidated Balance Sheets

 
81

Consolidated Statements of Cash Flows

 
82

Consolidated Statements of Stockholders' Equity

 
83

Notes to Consolidated Financial Statements

 
84
 

Note 1: Summary of Significant Accounting Policies

 
84
 

Note 2: Stock-Based Compensation

 
95
 

Note 3: Net Earnings Per Share

 
102
 

Note 4: Balance Sheet Details

 
104
 

Note 5: Supplemental Cash Flow Information

 
106
 

Note 6: Acquisitions

 
106
 

Note 7: Goodwill and Purchased Intangible Assets

 
108
 

Note 8: Restructuring Charges

 
110
 

Note 9: Fair Value

 
111
 

Note 10: Financial Instruments

 
115
 

Note 11: Financing Receivables and Operating Leases

 
121
 

Note 12: Guarantees

 
122
 

Note 13: Borrowings

 
123
 

Note 14: Taxes on Earnings

 
126
 

Note 15: Stockholders' Equity

 
132
 

Note 16: Retirement and Post-Retirement Benefit Plans

 
135
 

Note 17: Commitments

 
143
 

Note 18: Litigation and Contingencies

 
144
 

Note 19: Segment Information

 
152

Quarterly Summary

 
161

76


Table of Contents


Report of Independent Registered Public Accounting Firm

These excerpts taken from the HPQ 10-K filed Dec 18, 2008.

Equity price risk

        We are also exposed to equity price risk inherent in our portfolio of publicly-traded equity securities, which had an estimated fair value of $5 million at October 31, 2008 and $9 million at October 31, 2007. We monitor our equity investments for impairment on a periodic basis. In the event that the carrying value of the equity investment exceeds its fair value, and we determine the decline in value to be other than temporary, we reduce the carrying value to its current fair value. Generally, we do not attempt to reduce or eliminate our market exposure on these equity securities. However, we may use derivative transactions to hedge certain positions from time to time. We do not purchase our equity securities with the intent to use them for speculative purposes. A hypothetical 30% adverse change in the stock prices of our publicly-traded equity securities would result in a loss in the fair values of our marketable equity securities of $2 million at October 31, 2008 and $3 million at October 31, 2007. The aggregate cost of privately-held companies, marketable trading securities and other investments was $425 million at October 31, 2008 and $533 million at October 31, 2007.

75


Table of Contents


ITEM 8. Financial Statements and Supplementary Data.


Table of Contents

Reports of Independent Registered Public Accounting Firm

  77

Management's Report on Internal Control Over Financial Reporting

 
80

Consolidated Statements of Earnings

 
81

Consolidated Balance Sheets

 
82

Consolidated Statements of Cash Flows

 
83

Consolidated Statements of Stockholders' Equity

 
84

Notes to Consolidated Financial Statements

 
85
 

Note 1: Summary of Significant Accounting Policies

 
85
 

Note 2: Stock-Based Compensation

 
95
 

Note 3: Net Earnings Per Share

 
102
 

Note 4: Balance Sheet Details

 
104
 

Note 5: Supplemental Cash Flow Information

 
106
 

Note 6: Acquisitions

 
106
 

Note 7: Goodwill and Purchased Intangible Assets

 
111
 

Note 8: Restructuring Charges

 
113
 

Note 9: Financial Instruments

 
115
 

Note 10: Financing Receivables and Operating Leases

 
120
 

Note 11: Guarantees

 
121
 

Note 12: Borrowings

 
122
 

Note 13: Taxes on Earnings

 
126
 

Note 14: Stockholders' Equity

 
131
 

Note 15: Retirement and Post-Retirement Benefit Plans

 
133
 

Note 16: Commitments

 
143
 

Note 17: Litigation and Contingencies

 
144
 

Note 18: Segment Information

 
151

Quarterly Summary

 
159

76


Table of Contents


Report of Independent Registered Public Accounting Firm

Equity price risk



        We are also exposed to equity price risk inherent in our portfolio of publicly-traded equity securities, which had an estimated fair
value of $5 million at October 31, 2008 and $9 million at October 31, 2007. We monitor our equity investments for impairment on a periodic basis. In the event that the
carrying value of the equity investment exceeds its fair value, and we determine the decline in value to be other than temporary, we reduce the carrying value to its current fair value. Generally, we
do not attempt to reduce or eliminate our market exposure on these equity securities. However, we may use derivative transactions to hedge certain positions from time to time. We do not purchase our
equity securities with the intent to use them for speculative purposes. A hypothetical 30%
adverse change in the stock prices of our publicly-traded equity securities would result in a loss in the fair values of our marketable equity securities of $2 million at October 31,
2008 and $3 million at October 31, 2007. The aggregate cost of privately-held companies, marketable trading securities and other investments was $425 million at
October 31, 2008 and $533 million at October 31, 2007.



75









NAME="page_fa72001_1_76">








































Table of Contents



NAME="fa72001_item_8._financial_statements_and_supplementary_data.">

ITEM 8. Financial Statements and Supplementary Data.



NAME="fa72001_table_of_contents">

Table of Contents



































































































































































Reports of Independent Registered Public Accounting Firm

 77

Management's Report on Internal Control Over Financial
Reporting

 

80

Consolidated Statements of Earnings

 

81

Consolidated Balance Sheets

 

82

Consolidated Statements of Cash Flows

 

83

Consolidated Statements of Stockholders'
Equity

 

84

Notes to Consolidated Financial Statements

 

85
 

Note 1: Summary of Significant Accounting
Policies

 

85
 

Note 2: Stock-Based Compensation

 

95
 

Note 3: Net Earnings Per Share

 

102
 

Note 4: Balance Sheet Details

 

104
 

Note 5: Supplemental Cash Flow
Information

 

106
 

Note 6: Acquisitions

 

106
 

Note 7: Goodwill and Purchased Intangible
Assets

 

111
 

Note 8: Restructuring Charges

 

113
 

Note 9: Financial Instruments

 

115
 

Note 10: Financing Receivables and Operating
Leases

 

120
 

Note 11: Guarantees

 

121
 

Note 12: Borrowings

 

122
 

Note 13: Taxes on Earnings

 

126
 

Note 14: Stockholders' Equity

 

131
 

Note 15: Retirement and Post-Retirement Benefit
Plans

 

133
 

Note 16: Commitments

 

143
 

Note 17: Litigation and Contingencies

 

144
 

Note 18: Segment Information

 

151

Quarterly Summary

 

159



76









NAME="page_fc72001_1_77">








































Table of Contents



NAME="fc72001_report_of_independent___fc702274">


Report of Independent Registered Public Accounting Firm




This excerpt taken from the HPQ 10-K filed Dec 18, 2007.

Equity price risk

        We are also exposed to equity price risk inherent in our portfolio of publicly-traded equity securities, which had an estimated fair value of $9 million at October 31, 2007 and $36 million at October 31, 2006. We monitor our equity investments for impairment on a periodic basis. In the event that the carrying value of the equity investment exceeds its fair value, and we determine the decline in value to be other than temporary, we reduce the carrying value to its current fair value. Generally, we do not attempt to reduce or eliminate our market exposure on these equity securities. However, we may use derivative transactions to hedge certain positions from time to time. We do not purchase our equity securities with the intent to use them for speculative purposes. A hypothetical 30% adverse change in the stock prices of our publicly-traded equity securities would result in a loss in the fair values of our marketable equity securities of $3 million at October 31, 2007 and $11 million at October 31, 2006. The aggregate cost of privately-held companies and other investments was $533 million at October 31, 2007 and $362 million at October 31, 2006.

70



ITEM 8. Financial Statements and Supplementary Data.


Table of Contents

Reports of Independent Registered Public Accounting Firm
Management's Report on Internal Control Over Financial Reporting
Consolidated Statements of Earnings
Consolidated Balance Sheets
Consolidated Statements of Cash Flows
Consolidated Statements of Stockholders' Equity
Notes to Consolidated Financial Statements
  Note 1: Summary of Significant Accounting Policies
  Note 2: Stock-Based Compensation
  Note 3: Net Earnings Per Share
  Note 4: Balance Sheet Details
  Note 5: Supplemental Cash Flow Information
  Note 6: Acquisitions
  Note 7: Goodwill and Purchased Intangible Assets
  Note 8: Restructuring Charges
  Note 9: Financial Instruments
  Note 10: Financing Receivables and Operating Leases
  Note 11: Guarantees
  Note 12: Borrowings
  Note 13: Taxes on Earnings
  Note 14: Stockholders' Equity
  Note 15: Retirement and Post-Retirement Benefit Plans
  Note 16: Commitments
  Note 17: Litigation and Contingencies
  Note 18: Segment Information
Quarterly Summary

71



Report of Independent Registered Public Accounting Firm

This excerpt taken from the HPQ 10-K filed Dec 22, 2006.

Equity price risk

        We are also exposed to equity price risk inherent in our portfolio of publicly-traded equity securities, which had an estimated fair value of $36 million at October 31, 2006 and $64 million at October 31, 2005. We monitor our equity investments for impairment on a periodic basis. In the event that the carrying value of the equity investment exceeds its fair value, and we determine the decline in value to be other than temporary, we reduce the carrying value to its current fair value. Generally, we do not attempt to reduce or eliminate our market exposure on these equity securities. However, we may use derivative transactions to hedge certain positions from time to time. We do not purchase our equity securities with the intent to use them for trading or speculative purposes. A hypothetical 30% adverse change in the stock prices of our publicly-traded equity securities would result in a loss in the fair values of our marketable equity securities of $11 million at October 31, 2006 and $19 million at October 31, 2005. The aggregate cost of privately-held companies and other investments is $362 million at October 31, 2006 and $353 million at October 31, 2005.

69



ITEM 8. Financial Statements and Supplementary Data.


Table of Contents

Report of Independent Registered Public Accounting Firm   71
Management's Report on Internal Control Over Financial Reporting   73
Consolidated Statements of Earnings   74
Consolidated Balance Sheets   75
Consolidated Statements of Cash Flows   76
Consolidated Statements of Stockholders' Equity   77
Notes to Consolidated Financial Statements   78
  Note 1: Summary of Significant Accounting Policies   78
  Note 2: Stock-Based Compensation   86
  Note 3: Net Earnings Per Share ("EPS")   92
  Note 4: Balance Sheet Details   93
  Note 5: Supplemental Cash Flow Information   95
  Note 6: Acquisitions   95
  Note 7: Goodwill and Purchased Intangible Assets   98
  Note 8: Restructuring Charges   99
  Note 9: Financial Instruments   101
  Note 10: Financing Receivables and Operating Leases   106
  Note 11: Guarantees   107
  Note 12: Borrowings   108
  Note 13: Taxes on Earnings   111
  Note 14: Stockholders' Equity   115
  Note 15: Retirement and Post-Retirement Benefit Plans   117
  Note 16: Commitments   126
  Note 17: Litigation and Contingencies   127
  Note 18: Segment Information   134
Quarterly Summary   141

70



Report of Independent Registered Public Accounting Firm

This excerpt taken from the HPQ 10-K filed Dec 21, 2005.

Equity price risk

        We also are exposed to equity price risk inherent in our portfolio of publicly-traded equity securities, which had an estimated fair value of $64 million at October 31, 2005 and $70 million at October 31, 2004. We monitor our equity investments for impairment on a periodic basis. In the event that the carrying value of the equity investment exceeds its fair value, and we determine the decline in value to be other than temporary, we reduce the carrying value to its current fair value. Generally, we do not attempt to reduce or eliminate our market exposure on these equity securities. However, we may use derivative transactions to hedge certain positions from time to time. We do not purchase our equity securities with the intent to use them for trading or speculative purposes. A hypothetical 30% adverse change in the stock prices of our publicly-traded equity securities would result in a loss in the fair values of our marketable equity securities of $19 million at October 31, 2005 and $21 million at October 31, 2004. The aggregate cost of privately-held companies and other investments is $353 million at October 31, 2005 and $388 million at October 31, 2004.

66



ITEM 8. Financial Statements and Supplementary Data.

TABLE OF CONTENTS

Report of Independent Registered Public Accounting Firm   68
Management's Report on Internal Control Over Financial Reporting   70
Consolidated Statements of Earnings   71
Consolidated Balance Sheets   72
Consolidated Statements of Cash Flows   73
Consolidated Statements of Stockholders' Equity   74
Notes to Consolidated Financial Statements   75
  Note 1: Summary of Significant Accounting Policies   75
  Note 2: Net Earnings Per Share ("EPS")   84
  Note 3: Balance Sheet Details   85
  Note 4: Supplemental Cash Flow Information   87
  Note 5: Acquisitions   87
  Note 6: Goodwill and Purchased Intangible Assets   90
  Note 7: Restructuring Charges   91
  Note 8: Financial Instruments   94
  Note 9: Financing Receivables and Operating Leases   98
  Note 10: Guarantees   99
  Note 11: Borrowings   101
  Note 12: Taxes on Earnings   103
  Note 13: Stockholders' Equity   107
  Note 14: Comprehensive Income   110
  Note 15: Retirement and Post-Retirement Benefit Plans   111
  Note 16: Commitments   119
  Note 17: Litigation and Contingencies   120
  Note 18: Segment Information   129
Quarterly Summary   135

67



Report of Independent Registered Public Accounting Firm

This excerpt taken from the HPQ 10-K filed Jan 14, 2005.

Equity price risk

        During the preceding fiscal year, we also were exposed to equity price risk inherent in our portfolio of publicly-traded equity securities, which had an estimated fair value of $70 million at October 31, 2004 and $97 million at October 31, 2003. We monitor our equity investments on a periodic basis. In the event that the carrying value of the equity investment exceeds its fair value, and the decline in value is determined to be other-than temporary, the carrying value is reduced to its current fair value. Generally, we do not attempt to reduce or eliminate our market exposure on these equity securities. However, we may use derivative transactions to hedge certain positions from time to time. We do not purchase our equity securities with the intent to use them for trading or speculative purposes. A hypothetical 30% adverse change in the stock prices of our publicly-traded equity securities would result in a loss in the fair values of our marketable equity securities of $21 million at October 31, 2004 and $29 million at October 31, 2003. The aggregate cost of privately-held companies and other investments is $388 million at October 31, 2004 and $577 million at October 31, 2003.

        Actual gains and losses in the future may differ materially from the sensitivity analyses based on changes in the timing and amount of interest rate, foreign currency exchange rate and equity price movements and our actual exposures and hedges.

81



ITEM 8. Financial Statements and Supplementary Data.


TABLE OF CONTENTS


 

 

 
Report of Independent Registered Public Accounting Firm   83
Statement of Management Responsibility   84
Consolidated Statements of Operations   85
Consolidated Balance Sheets   86
Consolidated Statements of Cash Flows   87
Consolidated Statements of Stockholders' Equity   88
Notes to Consolidated Financial Statements   89
Quarterly Summary   149

82



Report of Independent Registered Public Accounting Firm

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki